Compare, Analyse Aurobindo Pharma with MYLAN INC. - US - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

AUROBINDO PHARMA vs MYLAN (US) - Comparison Results

AUROBINDO PHARMA     Change

Aurobindo Pharma is one of India's top 5 pharma companies in terms of turnover, and has presence in the generic and Active Pharmaceutical Ingredients (API) segments. The company's robust product portfolio is spread across 6 product areas, including a... More

MYLAN (US)
   Change

Mylan is one of the worlds leading generics and specialty pharmaceutical company. Its products span to customers in about 140 countries across the world. The company maintains one of the industrys broadest and highest quality product portfolios, wh... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 AUROBINDO PHARMA   MYLAN
EQUITY SHARE DATA
    AUROBINDO PHARMA
Mar-19
MYLAN
Dec-18
AUROBINDO PHARMA/
MYLAN
5-Yr Chart
Click to enlarge
High Rs8303,498-   
Low Rs5271,925-   
Sales per share (Unadj.) Rs333.91,609.6-  
Earnings per share (Unadj.) Rs40.443.7-  
Cash flow per share (Unadj.) Rs51.8345.1-  
Dividends per share (Unadj.) Rs2.500-  
Dividend yield (eoy) %0.40-  
Book value per share (Unadj.) Rs237.11,741.3-  
Shares outstanding (eoy) m585.91514.50-   
Bonus / Rights / Conversions ESOP--  
Price / Sales ratio x2.01.7 120.6%   
Avg P/E ratio x16.862.0 27.1%  
P/CF ratio (eoy) x13.17.9 166.8%  
Price / Book Value ratio x2.91.6 183.8%  
Dividend payout %6.20-   
Avg Mkt Cap Rs m397,5691,395,211 28.5%   
No. of employees `00017.935.0 51.0%   
Total wages/salary Rs m25,8490-   
Avg. sales/employee Rs Th10,956.923,661.7 46.3%   
Avg. wages/employee Rs Th1,447.70-   
Avg. net profit/employee Rs Th1,324.3642.5 206.1%   
INCOME DATA
Net Sales Rs m195,636828,159 23.6%  
Other income Rs m1,5530-   
Total revenues Rs m197,189828,159 23.8%   
Gross profit Rs m39,519214,297 18.4%  
Depreciation Rs m6,680155,064 4.3%   
Interest Rs m2,62639,832 6.6%   
Profit before tax Rs m31,76719,401 163.7%   
Minority Interest Rs m270-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m-8810-   
Tax Rs m7,269-3,087 -235.5%   
Profit after tax Rs m23,64522,488 105.1%  
Gross profit margin %20.225.9 78.1%  
Effective tax rate %22.9-15.9 -143.8%   
Net profit margin %12.12.7 445.1%  
BALANCE SHEET DATA
Current assets Rs m153,645462,443 33.2%   
Current liabilities Rs m120,429337,172 35.7%   
Net working cap to sales %17.015.1 112.2%  
Current ratio x1.31.4 93.0%  
Inventory Days Days13584 161.8%  
Debtors Days Days6493 68.3%  
Net fixed assets Rs m103,909160,649 64.7%   
Share capital Rs m586441 132.9%   
"Free" reserves Rs m138,3220-   
Net worth Rs m138,908895,917 15.5%   
Long term debt Rs m1,800966,981 0.2%   
Total assets Rs m264,5442,403,196 11.0%  
Interest coverage x13.11.5 880.7%   
Debt to equity ratio x01.1 1.2%  
Sales to assets ratio x0.70.3 214.6%   
Return on assets %9.92.6 383.0%  
Return on equity %17.02.5 678.2%  
Return on capital %23.83.2 749.7%  
Exports to sales %49.60-   
Imports to sales %18.80-   
Net fx Rs m56,7270-   
CASH FLOW
From Operations Rs m16,220172,092 9.4%  
From Investments Rs m-28,768-88,952 32.3%  
From Financial Activity Rs m19,191-80,170 -23.9%  
Net Cashflow Rs m6,6561,426 466.9%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for MYLAN (US) is United States Dollars. All data has been converted at 73.49 Rs / USD

Compare AUROBINDO PHARMA With: ADCOCK INGRAM (S. Africa)  ACTAVIS (US)  TEVA PHARMA (Israel)  

Compare AUROBINDO PHARMA With: ORCHID PHARMA  J.B.CHEMICALS  ELDER PHARMA  PIRAMAL ENTERPRISES  SHASUN PHARMA  



Today's Market

Sensex, Nifty End Flat; Asian Paints, UPL & ITC Among Top Gainers(Closing)

Indian share markets witnessed volatile trading activity throughout the day today and ended on a flat note.

Related Views On News

AUROBINDO PHARMA Announces Quarterly Results (1QFY21); Net Profit Up 25.6% (Quarterly Result Update)

Sep 15, 2020 | Updated on Sep 15, 2020

For the quarter ended June 2020, AUROBINDO PHARMA has posted a net profit of Rs 8 bn (up 25.6% YoY). Sales on the other hand came in at Rs 59 bn (up 8.8% YoY). Read on for a complete analysis of AUROBINDO PHARMA's quarterly results.

AUROBINDO PHARMA Announces Quarterly Results (4QFY20); Net Profit Up 48.2% (Quarterly Result Update)

Jun 5, 2020 | Updated on Jun 5, 2020

For the quarter ended March 2020, AUROBINDO PHARMA has posted a net profit of Rs 9 bn (up 48.2% YoY). Sales on the other hand came in at Rs 62 bn (up 16.4% YoY). Read on for a complete analysis of AUROBINDO PHARMA's quarterly results.

Dr Reddy's Lab Shares Fall As Earnings Miss Estimates. What Next? (Views On News)

May 14, 2021

The company's board recommended a final dividend of Rs 25 for financial year 2020-21.

What's Behind the Rally in Pharma Stocks? (Views On News)

May 11, 2021

The second wave of Covid has given a new lease of life to pharma stocks.

Why Did Alembic Pharma Shares Fall Today? (Views On News)

May 5, 2021

Covid-led supply disruptions of API fuel Alembic Pharma's global prospects.

More Views on News

Most Popular

Is Intraday Trading For You? (Fast Profits Daily)

May 13, 2021

Do you think you have what it takes to be an intraday trader? Find out in this video.

My Secret to Find Breakthrough Stocks (Fast Profits Daily)

May 7, 2021

I've used this trading technique for many years with great success. I'm sharing it with you today.

Are the Stock Markets Deaf to Covid Agony? (Profit Hunter)

May 6, 2021

Why are markets discounting the economic impact of Covid?

The Key to Profit from India's EV Revolution (Profit Hunter)

May 7, 2021

Stocks you must consider investing in before buying your first electric vehicle.

More
-->

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

OUR TOP 5 IDEAS

New Research: Our #1 Stock Pick Right Now
Are You Making One of These 15 Costly Mistakes While Investing. Learn more!
Covid-19 Proof Multibagger Stocks - Download this FREE Report Now
Free Report: The Secret to Increasing Your Trading Profits Daily!
No Guessing, No Hunches, and No Missed Trends Ever! Join Us on YouTube Now.

AUROBINDO PHARMA SHARE PRICE


May 14, 2021 (Close)

TRACK AUROBINDO PHARMA

  • Track your investment in AUROBINDO PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON AUROBINDO PHARMA

AUROBINDO PHARMA 8-QTR ANALYSIS

COMPARE AUROBINDO PHARMA WITH

FEATURED VIDEOS

Top Pick for Next Decade

The 'Big' Money is in this 'Small' Detail

Stability, Quality or Green Stocks for 2021?

Market Crash: Picture Abhi Baaki Hai?

More Featured Videos

MARKET STATS